S, T., N, L., A, D., A, D., A, U., M, V., . . . B, D. (2022). Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals. PLoS pathogens, 18(9), e1010799. https://doi.org/10.1371/journal.ppat.1010799
Chicago Style (17th ed.) CitationS, Thébault, et al. "Biosynthetic Proteins Targeting the SARS-CoV-2 Spike as Anti-virals." PLoS Pathogens 18, no. 9 (2022): e1010799. https://doi.org/10.1371/journal.ppat.1010799.
MLA (9th ed.) CitationS, Thébault, et al. "Biosynthetic Proteins Targeting the SARS-CoV-2 Spike as Anti-virals." PLoS Pathogens, vol. 18, no. 9, 2022, p. e1010799, https://doi.org/10.1371/journal.ppat.1010799.
Warning: These citations may not always be 100% accurate.